Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen‐specific <scp>IgE</scp> production-Reference-Cited by-同舟云学术

Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen‐specific IgE production

Published:2023-02-03 Issue:6 Volume:78 Page:1687-1691
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Campion Nicholas James¹,Doralt Anna¹,Lupinek Christian²,Berger Markus³,Poglitsch Katharina⁴,Brugger Jonas⁵,Quint Tamara⁴^ORCID,Gangl Katharina¹,Sinz Christoph⁴,Bartosik Tina¹,Liu David Tianxiang¹,Landegger Lukas David¹^ORCID,Tu Aldine¹,Stanek Victoria¹,Berger Uwe¹,Bangert Christine⁴,Schneider Sven¹,Eckl‐Dorna Julia¹

Affiliation:

1. Department of Otorhinolaryngology General Hospital and Medical University of Vienna Vienna Austria

2. MacroArray Diagnostics Vienna Austria

3. Department of Otorhinolaryngology Wiener Gesundheitsverbund, Hospital Hietzing Vienna Austria

4. Department of Dermatology General Hospital and Medical University of Vienna Vienna Austria

5. Center for Medical Statistics, Informatics and Intelligent Systems Medical University of Vienna Vienna Austria

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15653

Reference12 articles.

1. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

2. Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases

3. Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial

4. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti–IL-4: A randomized controlled trial

5. Antigens Drive Memory IgE Responses in Human Allergy via the Nasal Mucosa

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endotyping Chronic Respiratory Diseases: T2 Inflammation in the United Airways Model;Life;2024-07-19

2. Adoptive Cell Therapy in Mice Sensitized to a Grass Pollen Allergen;Antibodies;2024-06-18

3. Dupilumab dampens mucosal type 2 response during acetylsalicylic acid challenge in N-ERD patients;2024-06-07

4. Effect of dupilumab on asthma and aeroallergen sensitization in pediatric atopic dermatitis patients: Results of the BioDay registry;Pediatric Allergy and Immunology;2024-06

5. TGF-β, IL-1β, IL-6 levels and TGF-β/Smad pathway reactivity regulate the link between allergic diseases, cancer risk, and metabolic dysregulations;Frontiers in Immunology;2024-04-02